Thyroid cancer is the 8th common malignancy accounting 3% of all cancers in women. It is an aggressive disease in Pakistan. Incidence of thyroid cancer is estimated between 5 and 8 cases per 105 inhabitants per year in developed countries. BRAF mutations occur with a frequency of 8% and ranks behind RAS mutation which is 15% as the second most common somatic mutation in human cancer. In more than 80% cases T→A transversion at position 1799 (BRAF V600E) is involved. These are somatic missense mutations in which valine to glutamate substitution occurs at position 600 leading to abnormal activation of the B-Raf kinase that is involved in signal transduction pathway and control cellular growth. In present study, mutational analysis of BRAF gene in exon 15 has been done by mutant allele specific PCR amplification followed by SSCP. Both are sensitive, reliable, fast, safe and convenient methods for mutational analysis. After DNA extraction, 1(2.85%) mutation in BRAF was observed in sample 9 which was follicular variant of PTC by SSCP analysis indicating the band shift as compared to control but no mutation was detected in sample no. 2, 14 and 15 which were follicular adenomas and goiter. Statistical analysis indicates that thyroid cancer occurs at high frequency in females. Follicular thyroid cancer occurs at high frequency in patients falling in 26-36 age group, papillary thyroid cancer occurs in 48-58 age group patients and medullary thyroid cancer occurs in 37-47 age group patients. Follicular adenoma occurs at lowest frequency in 59-69 age group patients. Chi square analysis provide significant results about various clinicopathological features. P-value is greater than 0.05 so the results are insignificant indicating that males are less susceptible and ratio of females is greater having thyroid cancer. There is no association between 15-25 and 26-36 age groups and occurrence of the cancer (P-value > 0.05). But there is an association between 37-47 and 48-58 age groups and occurrence of the thyroid cancer (P-value 0.05).